BeStock  
Stocks › Biotechnology › SGP

SpyGlass Pharma SGP

US equityMarket cap rank #3409Biotechnology
$23.90 −$0.88 (-3.55%)
Market closed · Oct 8, 4:10 am ET · Last extended-hours $23.90 0.00%
Open$24.46
Prev close$24.78
Day range$23.62 – $24.76
Volume69.5K
Market cap$799.41M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership94.6%-0.02 pts vs. prior quarter
Institutions holding69+0 vs. prior quarter
Insider trades (recent)21 buys / 0 sellsNet buying
Short interest3.68% of floatDays to cover 11.6 · as of 15 Sep 2026
Short-sale volume share21.6%5-day average of daily volume

Short-sale volume as % of daily volume

12%17%23%29%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$332.6K (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$338.6KSuper+$6,025Big−$116.8KMid+$549.0KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 70.0% of shares outstanding.

Largest holders

  • RA Capital Management, L.P.23.98%
  • New Enterprise Associates, Inc.22.10%
  • Vensana Capital Management, LLC9.90%
  • Sands Capital Alternatives, LLC7.47%
  • Gilde Healthcare Partners BV6.54%
  • Samsara BioCapital LLC6.31%
  • Malik Kahook2.61%
  • BlackRock2.13%

By investor type

  • VC/PE Fund76.30%
  • Mutual Fund12.38%
  • Hedge Fund5.73%
  • Individual/Insider4.28%
  • Public Company0.14%
  • Insurance Company0.04%
  • Government Pension Fund0.03%
  • Private Company0.01%

Reported short interest has fallen from 3.92% to 3.68% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Nuveen Asset Management LLC Insurance Company 2026/Q3 +14,649 0.0%
BlackRock Mutual Fund 2026/Q3 +566,973 2.1%
abrdn plc Mutual Fund 2026/Q3 +272,622 1.5%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +150,785 0.8%
State Street Global Advisors Mutual Fund 2026/Q3 +100,311 0.4%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +72,132 0.2%
Northern Trust Global Investments Mutual Fund 2026/Q3 +61,589 0.2%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +48,967 1.8%
Millennium Management LLC Hedge Fund 2026/Q3 +38,463 1.5%
ALPS Advisors, Inc. Mutual Fund 2026/Q3 +33,932 0.1%
Charles Schwab Investment Management Mutual Fund 2026/Q3 +26,071 0.3%
BNY Mellon Asset Management Mutual Fund 2026/Q3 +23,944 0.1%
Virtus Investment Advisers, LLC Mutual Fund 2026/Q3 +17,744 0.1%
Teachers Insurance and Annuity Association-College Retirement Equities Fund Mutual Fund 2026/Q3 +14,649 0.0%
Rhumbline Advisers Ltd Partnership Mutual Fund 2026/Q3 +11,844 0.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
8 Feb 2026 New Enterprise Associates, Inc. Private Acquisition +937,500 $16.00 7,392,301
8 Feb 2026 New Enterprise Associates, Inc. Derivative Exercise and Retained +6,454,801 – 7,392,301
8 Feb 2026 RA Capital Management, L.P. Private Acquisition +3,690,000 $16.00 8,021,117
8 Feb 2026 RA Capital Management, L.P. Derivative Exercise and Retained +4,331,117 – 8,021,117
8 Feb 2026 Gilde Healthcare Partners BV Private Acquisition +312,500 $16.00 2,187,513
8 Feb 2026 Gilde Healthcare Partners BV Derivative Exercise and Retained +1,875,013 – 2,187,513
8 Feb 2026 Bilal Khan Independent Director Private Acquisition +135,000 $16.00 276,877
4 Feb 2026 Scott Sandell Initial Statement of Beneficial +0 – 737,962
4 Feb 2026 Geoffrey Pardo Independent Director Other Derivative Acquisition +27,400 $16.00 27,400
4 Feb 2026 Mohamad Makhzoumi Initial Statement of Beneficial +0 – 737,962
4 Feb 2026 Elizabeth O'Farrell Other Derivative Acquisition +13,700 $16.00 13,700
4 Feb 2026 Elizabeth O'Farrell Initial Statement of Beneficial +0 – 65,976
4 Feb 2026 RA Capital Management, L.P. Other Derivative Acquisition +27,400 $16.00 27,400
4 Feb 2026 RA Capital Management, L.P. Initial Statement of Beneficial +0 – 494,647
4 Feb 2026 Jean-Frederic Viret Chief Financial Officer Other Derivative Acquisition +17,500 $16.00 17,500
4 Feb 2026 Jean-Frederic Viret Chief Financial Officer Initial Statement of Beneficial +0 – 263,907
4 Feb 2026 Kirk Nielsen Other Derivative Acquisition +27,400 $16.00 27,400
4 Feb 2026 Michael Dybbs Independent Director Other Derivative Acquisition +27,400 $16.00 27,400
4 Feb 2026 Malik Kahook Co-Founder, President, Chief Medical Officer & Executive Chairman Other Derivative Acquisition +105,000 $16.00 105,000
4 Feb 2026 Malik Kahook Co-Founder, President, Chief Medical Officer & Executive Chairman Initial Statement of Beneficial +0 – 434,738

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 1,229,711 3.7% 11.6
31 Aug 2026 1,096,948 3.3% 15.8
14 Aug 2026 1,136,810 3.4% 15.2
31 Jul 2026 1,140,494 3.4% 12.1
15 Jul 2026 1,130,776 3.4% 7.9
30 Jun 2026 1,310,944 3.9% 5.5

Discussion

No comments yet — be the first to weigh in on SGP.

Leave a comment

Scroll to Top